Plain language summary: real-world effectiveness of Ceftazidime-Avibactam combination therapy for bacterial diseases

This Plain Language Summary of Publication article (PLSP) from Future Microbiology examines Ceftazidime-Avibactam (CAZ-AVI), an antibiotic combination used against resistant bacterial infections. The research involved hospitalized patients from Europe and Latin America who received CAZ-AVI when conventional antibiotics failed. The study investigated which types of bacterial infections doctors treated with CAZ-AVI, addressing the growing concern of antibiotic resistance that leads to extended hospital stays, increased disability, financial losses, and mortality risk.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘The Use and Effectiveness of Ceftazidime–Avibactam in Real-World Clinical Practice: EZTEAM Study’ and was published in Infectious Diseases and Therapy.

Visit Springer Nature Link using the link to read the original article.

• Ceftazidime-avibactam
• Europe
• Gram-negative bacteria
• LATAM
• Multidrug-resistant
• plain language summary